|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,601.00 INR | +0.31% |
|
-1.98% | +5.26% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 3,081 | +18.82% | 4 | ||||||
| 1,292.53 | +9.01% | 27 | ||||||
| 272.5 | +5.12% | 22 | ||||||
| 274.36 | +11.51% | 28 | ||||||
| 370.31 | +0.82% | 18 | ||||||
| 154.05 | -1.22% | 21 | ||||||
| 211.55 | +31.78% | 22 | ||||||
| 378.31 | -7.94% | 29 | ||||||
| 314.24 | +3% | 24 | ||||||
| 157.41 | +18.16% | 27 | ||||||
| 28.64 | +7.04% | 26 | ||||||
| 66.21 | +2.3% | 24 | ||||||
| 559.28 | +12.74% | 25 | ||||||
| 21.51 | +9.73% | 20 | ||||||
| 94.45 | +25.42% | 23 | ||||||
| 9,513.33 | +38.74% | 15 | ||||||
| 56.81 | +14.04% | 18 | ||||||
| 6,387.69 | +15.3% | 16 | ||||||
| 80.33 | +47.08% | 15 | ||||||
| 4.196 | +13.6% | 17 | ||||||
| Average | 1,165.94 | +13.75% | 21 | ||||||
| Weighted average by Cap. | 711.25 | +9.21% | 24 |
Select your edition
All financial news and data tailored to specific country editions
